Cumberland Pharmaceuticals Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
Cumberland Pharmaceuticals Inc. (CPIX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $0 for the 12-month period ending 2019-12-31, per its 8-K filed 2020-12-10.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2020-12-10
- Cumberland Pharmaceuticals Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
- Cumberland Pharmaceuticals Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2015 was $3.88K.
- Cumberland Pharmaceuticals Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2014 was $0.00, a 100.00% decline from fiscal 2013.
- Cumberland Pharmaceuticals Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2013 was $212.44K, a 57.12% decline from fiscal 2012.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month |
|---|---|
| 2019-12-31 | $0.00 8-K · filed 2020-12-10 |
| 2018-12-31 | $0.00 8-K · filed 2020-12-10 |
| 2017-12-31 | $0.00 8-K · filed 2020-12-10 |
| 2016-12-31 | $0.00 10-K · filed 2019-03-12 |
| 2015-12-31 | $3.88K 10-K · filed 2018-03-09 |
| 2014-12-31 | $0.00 10-K · filed 2017-03-13 |
| 2013-12-31 | $212.44K 10-K · filed 2016-03-14 |
| 2012-12-31 | $495.48K 10-K · filed 2015-03-09 |
| 2011-12-31 | $1.74M 10-K · filed 2014-03-11 |
| 2010-12-31 | $5.52M 10-K · filed 2013-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |